Know Labs, Inc. KNWN
We take great care to ensure that the data presented and summarized in this overview for KNOW LABS, INC. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in KNWN
Top Purchases
Top Sells
About KNWN
Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.
Insider Transactions at KNWN
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 05
2025
|
John E Cronin Director |
BUY
Grant, award, or other acquisition
|
Indirect |
25,000
+50.0%
|
$0
$0.44 P/Share
|
|
May 05
2025
|
John E Cronin Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+49.6%
|
$0
$0.44 P/Share
|
|
May 05
2025
|
William Arthur Owens Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.93%
|
$0
$0.44 P/Share
|
|
May 05
2025
|
Ronald P Erickson CEO |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+42.16%
|
$0
$0.44 P/Share
|
|
May 05
2025
|
Peter J Conley Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
50,000
+49.88%
|
$0
$0.44 P/Share
|
|
May 05
2025
|
Jon Pepper Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+39.78%
|
$0
$0.44 P/Share
|
|
May 05
2025
|
Ichiro John Paul Takesako Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+46.4%
|
$0
$0.44 P/Share
|
|
May 05
2025
|
Larry K Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+49.6%
|
$0
$0.44 P/Share
|
|
May 24
2024
|
Jon Pepper Director |
SELL
Bona fide gift
|
Direct |
14,000
-2.65%
|
-
|
|
Feb 08
2024
|
Jon Pepper Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+15.92%
|
$0
$0.49 P/Share
|
|
Feb 08
2024
|
Larry K Ellingson Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,164
+50.0%
|
$0
$0.49 P/Share
|
|
Feb 08
2024
|
Timothy M Londergan Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,164
+48.5%
|
$0
$0.49 P/Share
|
|
Feb 08
2024
|
William Arthur Owens Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+9.54%
|
$0
$0.49 P/Share
|
|
Feb 08
2024
|
Ichiro John Paul Takesako Director |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+39.22%
|
$0
$0.49 P/Share
|
|
Feb 08
2024
|
John E Cronin Director |
BUY
Grant, award, or other acquisition
|
Direct |
16,164
+50.0%
|
$0
$0.49 P/Share
|
|
Oct 12
2023
|
William Arthur Owens Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+3.97%
|
$0
$0.25 P/Share
|
|
Oct 12
2023
|
Jon Pepper Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+7.56%
|
$0
$0.25 P/Share
|
|
Oct 12
2023
|
Ichiro John Paul Takesako Director |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+38.89%
|
$0
$0.25 P/Share
|
|
May 16
2023
|
William Arthur Owens Director |
BUY
Exercise of conversion of derivative security
|
Direct |
157,983
+16.28%
|
$0
$0.25 P/Share
|
|
Mar 31
2023
|
Ichiro John Paul Takesako Director |
SELL
Open market or private sale
|
Direct |
7,500
-27.27%
|
$0
$0.88 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 300K shares |
|---|